Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of CIS Insulin market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of CIS Insulinmarket, defines the market attractiveness level of CIS Insulin market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of CIS Insulin industry, describes the types of CIS Insulin market, the applications of major players and the market size, and deeply analyzes the current situation of the global CIS Insulin market and the development prospects and opportunities of CIS Insulin industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global CIS Insulin market in Chapter 13.
By Player:
Sanofi Aventis
Takeda Pharmaceuticals
Merck
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
Nanjing Xinbai Pharmaceutical
Biocon
Oramed Pharmaceuticals
By Type:
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin
By End-User:
Type I and Other Diabetes
Type II Diabetes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 CIS Insulin Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 CIS Insulin Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 CIS Insulin Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 CIS Insulin Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise CIS Insulin Market Analysis and Outlook to 2022
-
7.1 Global CIS Insulin Consumption (2017-2022)
-
7.2 United States CIS Insulin Consumption (2017-2022)
-
7.3 Europe CIS Insulin Consumption (2017-2022)
-
7.4 China CIS Insulin Consumption (2017-2022)
-
7.5 Japan CIS Insulin Consumption (2017-2022)
-
7.6 India CIS Insulin Consumption (2017-2022)
-
7.7 South Korea CIS Insulin Consumption (2017-2022)
8 Region and Country-wise CIS Insulin Market Analysis and Outlook to 2028
-
8.1 Global CIS Insulin Consumption Forecast (2022-2028)
-
8.2 United States CIS Insulin Consumption Forecast (2022-2028)
-
8.3 Europe CIS Insulin Consumption Forecast (2022-2028)
-
8.4 China CIS Insulin Consumption Forecast (2022-2028)
-
8.5 Japan CIS Insulin Consumption Forecast (2022-2028)
-
8.6 India CIS Insulin Consumption Forecast (2022-2028)
-
8.7 South Korea CIS Insulin Consumption Forecast (2022-2028)
9 Global CIS Insulin Market Outlook by Types and Applications to 2022
-
9.1 Global CIS Insulin Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Long-Acting Analog Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rapid Acting Analog Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Premixed Analog Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Intermediate Insulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Short Acting Insulin Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Premixed Insulin Consumption and Growth Rate (2017-2022)
-
9.2 Global CIS Insulin Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Type I and Other Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Type II Diabetes Consumption and Growth Rate (2017-2022)
10 Global CIS Insulin Market Outlook by Types and Applications to 2028
-
10.1 Global CIS Insulin Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Long-Acting Analog Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rapid Acting Analog Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Premixed Analog Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Intermediate Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Short Acting Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Premixed Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global CIS Insulin Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Type I and Other Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Type II Diabetes Consumption Forecast and Growth Rate (2022-2028)
11 Global CIS Insulin Import and Export Analysis (Top 5 Countries)
-
11.1 Global CIS Insulin Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global CIS Insulin Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 CIS Insulin Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global CIS Insulin Market Competitive Analysis
-
14.1 Sanofi Aventis
-
14.1.1 Sanofi Aventis Company Details
-
14.1.2 Sanofi Aventis CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Aventis CIS Insulin Product and Service
-
14.2 Takeda Pharmaceuticals
-
14.2.1 Takeda Pharmaceuticals Company Details
-
14.2.2 Takeda Pharmaceuticals CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Takeda Pharmaceuticals CIS Insulin Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck CIS Insulin Product and Service
-
14.4 Eli Lilly
-
14.4.1 Eli Lilly Company Details
-
14.4.2 Eli Lilly CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly CIS Insulin Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim CIS Insulin Product and Service
-
14.6 Novo Nordisk
-
14.6.1 Novo Nordisk Company Details
-
14.6.2 Novo Nordisk CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novo Nordisk CIS Insulin Product and Service
-
14.7 Nanjing Xinbai Pharmaceutical
-
14.7.1 Nanjing Xinbai Pharmaceutical Company Details
-
14.7.2 Nanjing Xinbai Pharmaceutical CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Nanjing Xinbai Pharmaceutical CIS Insulin Product and Service
-
14.8 Biocon
-
14.8.1 Biocon Company Details
-
14.8.2 Biocon CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biocon CIS Insulin Product and Service
-
14.9 Oramed Pharmaceuticals
-
14.9.1 Oramed Pharmaceuticals Company Details
-
14.9.2 Oramed Pharmaceuticals CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Oramed Pharmaceuticals CIS Insulin Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of CIS Insulin
-
Figure CIS Insulin Picture
-
Table Global CIS Insulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CIS Insulin Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CIS Insulin Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global CIS Insulin Consumption by Country (2017-2022)
-
Figure United States CIS Insulin Consumption and Growth Rate (2017-2022)
-
Table Europe CIS Insulin Consumption and Growth Rate (2017-2022)
-
Figure China CIS Insulin Consumption and Growth Rate (2017-2022)
-
Figure Japan CIS Insulin Consumption and Growth Rate (2017-2022)
-
Figure India CIS Insulin Consumption and Growth Rate (2017-2022)
-
Figure South Korea CIS Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global CIS Insulin Consumption Forecast by Country (2022-2028)
-
Figure United States CIS Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe CIS Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure China CIS Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan CIS Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure India CIS Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea CIS Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-Acting Analog Consumption and Growth Rate (2017-2022)
-
Figure Global Rapid Acting Analog Consumption and Growth Rate (2017-2022)
-
Figure Global Premixed Analog Consumption and Growth Rate (2017-2022)
-
Figure Global Intermediate Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Short Acting Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Premixed Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Type I and Other Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Type II Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Long-Acting Analog Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rapid Acting Analog Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Premixed Analog Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intermediate Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Short Acting Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Premixed Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type I and Other Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type II Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global CIS Insulin Import by Region (Top 5 Countries) (2017-2028)
-
Table Global CIS Insulin Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi Aventis CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Aventis CIS Insulin Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals CIS Insulin Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck CIS Insulin Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly CIS Insulin Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim CIS Insulin Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk CIS Insulin Product and Service
-
Table Nanjing Xinbai Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Nanjing Xinbai Pharmaceutical CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanjing Xinbai Pharmaceutical CIS Insulin Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon CIS Insulin Product and Service
-
Table Oramed Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Oramed Pharmaceuticals CIS Insulin Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oramed Pharmaceuticals CIS Insulin Product and Service
-
